Ruprecht-Karls-Universität Heidelberg

Evidence for γ-ray emission from the remnant of Kepleras supernova based on deep H.E.S.S. observations (2022) Aharonian F, Benkhali FA, Angüner EO, Ashkar H, Backes M, Martins VB, Batzofin R, et al. Journal article Well-Informed and Willing, but Breastfeeding Does Not Work: A Qualitative Study on Perceived Support from Health Professionals among German Mothers with Breastfeeding Problems (2022) Spannhake M, Jansen C, Görig T, Diehl K Journal article Working from home, hours worked and wages: Heterogeneity by gender and parenthood (2022) Arntz M, Ben Yahmed S, Berlingieri F Journal article Genome-wide studies reveal factors associated with circulating uromodulin and its relationships to complex diseases (2022) Li Y, Cheng Y, Consolato F, Schiano G, Chong MR, Pietzner M, Nguyen NQH, et al. Journal article New Approaches to the Study of Esotericism, by Egil Asprem and Julian Strube (eds.) (2022) Albrecht JA Journal article Mobilizing women voters: experimental evidence from Pakistan (2022) Chaudhry Z, Hussain K, Rehman AU Journal article VisuStatR: Visualizing motility and morphology statistics on images in R (2022) Harmel C, Ahmed SS, Koch R, Tunnermann J, Distler T, Imle A, Giorgetti L, et al. Journal article Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT (2022) Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema DJ, De Wreede LC, Blok HJ, Isaksson C, et al. Journal article Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B (2022) Furlanetto J, Marme F, Thode C, Nekljudova V, Liu Y, Jimenez MM, Reimer T, et al. Conference contribution Safety interim analysis (SIA) of the phase III postneoadjuvant SASCIA study evaluating sacituzumab govitecan (SG) in patients with primary HER2-negative breast cancer (BC) at high relapse risk after neoadjuvant treatment (2022) Marme F, Hanusch C, Furlanetto J, Morris P, Link T, Denkert C, Fasching P, et al. Conference contribution